DFT investigation of atazanavir as potential inhibitor for 2019-nCoV coronavirus M protease
. . Shahab S, Sheikhi M, Alnajjar R, Saud SA, Khancheuski M, Strogova A. . J Mol Struct. 2021 Mar 15;1228:129461. doi: 10.1016/j.molstruc.2020.129461. Epub 2020 Oct 17. Abstract Atazanavir (ATZ) is an antiviral drug synthesized.ATZ is being investigated for potential application against the Coronavirus 2019-nCoV. To find candidate drugs for 2019-nCoV, we have carried out a …